Aviva’s CryoPort CYRX Stock Holding History

Aviva’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-27,553	Closed	-$1.21M	–	953
2020 Q4	$1.21M	Sell	27,553 -22,338	-45%	-$1.06M	0.01%	835
2020 Q3	$2.37M	Sell	49,891 -29,053	-37%	-$1.18M	0.01%	636
2020 Q2	$2.39M	Sell	78,944 -149,615	-65%	-$3.33M	0.01%	591
2020 Q1	$3.9M	Buy	+228,559	New	+$4M	0.03%	469

Other funds holding CYRX

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Aviva's CYRX Position: Q1 2021 in Review

Aviva sold out of CryoPort (CYRX) in Q1 2021, closing a stake of 27,553 shares — an estimated $1.21M sold.

Aviva first reported a position in CYRX in Q1 2020 and held it in 4 quarters. The position peaked at $3.9M in Q1 2020. 210 funds tracked by Wall St. Rank hold CYRX as of Q1 2021.

Aviva reported no remaining CryoPort position as of Q1 2021 after selling out during the quarter.
Aviva sold 27,553 CryoPort shares in Q1 2021, an estimated $1.21M.
Aviva first reported a position in CryoPort in Q1 2020 and held it in 4 quarters.
Aviva's CryoPort position peaked at $3.9M in Q1 2020.
210 funds tracked by Wall St. Rank held CryoPort as of Q1 2021.

Based on Aviva's 13F filing for Q1 2021, filed 13 May 2021.